Oxcarbazepine add-on for drug-resistant partial epilepsy.

Author: CastilloS, SchmidtD B, WhiteS

Paper Details 
Original Abstract of the Article :
Most people with epilepsy have a good prognosis and their seizures can be well controlled with the use of a single antiepileptic drug, but up to 30 % develop refractory epilepsy, especially those with partial seizures. In this review we summarise the current evidence regarding oxcarbazepine when use...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD002028

データ提供:米国国立医学図書館(NLM)

Oxcarbazepine as Add-on Treatment for Drug-Resistant Partial Epilepsy

This review summarizes the current evidence on the effectiveness of oxcarbazepine as an add-on treatment for drug-resistant partial epilepsy. The authors highlight that while most individuals with epilepsy have a good prognosis and can manage their seizures with a single antiepileptic drug, approximately 30% develop refractory epilepsy, particularly those with partial seizures. The review analyzes the available evidence regarding oxcarbazepine's role in treating this challenging condition.

Oxcarbazepine: A Potential Adjunct Therapy for Refractory Epilepsy

The review suggests that oxcarbazepine may be a valuable add-on treatment option for individuals with drug-resistant partial epilepsy. This finding offers a potential avenue for improving seizure control in patients who have not responded adequately to standard therapies.

Living with Epilepsy: Seeking Comprehensive Care

If you are living with epilepsy, it's essential to seek comprehensive care from a neurologist or epileptologist. They can provide expert diagnosis, manage your condition, and guide you through the complex world of epilepsy treatments and management strategies.

Dr.Camel's Conclusion

This review, like a camel navigating the vast desert of epilepsy research, sheds light on the potential benefits of oxcarbazepine as an add-on therapy for drug-resistant partial epilepsy. The review offers valuable insights into the treatment landscape for individuals with epilepsy, highlighting the importance of exploring different therapeutic options to optimize seizure control and improve quality of life.

Date :
  1. Date Completed 2001-07-05
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

10908522

DOI: Digital Object Identifier

10.1002/14651858.CD002028

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.